These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2494743)

  • 1. First human clinical trial of melanoma neutron capture. Diagnosis and therapy.
    Mishima Y; Ichihashi M; Hatta S; Honda C; Yamamura K; Nakagawa T; Obara H; Shirakawa J; Hiratsuka J; Taniyama K
    Strahlenther Onkol; 1989; 165(2-3):251-4. PubMed ID: 2494743
    [No Abstract]   [Full Text] [Related]  

  • 2. Boronophenylalanine for neutron capture therapy of melanoma.
    Coderre JA; Glass JD; Fairchild RG; Micca P; Kalef-Ezra J
    Strahlenther Onkol; 1989; 165(2-3):215-7. PubMed ID: 2494733
    [No Abstract]   [Full Text] [Related]  

  • 3. RBE of thermal neutron capture therapy using 10B1-para-boronophenylalanine for human and B-16 melanoma cells.
    Ichihashi M; Sasase A; Hiramoto T; Mishima Y; Fukuda H; Kobayashi T
    Strahlenther Onkol; 1989; 165(2-3):198-201. PubMed ID: 2494727
    [No Abstract]   [Full Text] [Related]  

  • 4. Boronated monoclonal antibodies for potential neutron capture therapy of malignant melanoma and leukaemia.
    Tamat SR; Patwardhan A; Moore DE; Kabral A; Bradstock K; Hersey P; Allen BJ
    Strahlenther Onkol; 1989; 165(2-3):145-7. PubMed ID: 2494717
    [No Abstract]   [Full Text] [Related]  

  • 5. The incorporation of boronated substances into melanin in vitro--an experimental model for melanotic melanoma.
    Roberto A; Larsson BS
    Strahlenther Onkol; 1989; 165(2-3):165-7. PubMed ID: 2494722
    [No Abstract]   [Full Text] [Related]  

  • 6. [Selective affinity of 10B1-paraboronophenylalanine-HCl to malignant melanoma: thermal neutron capture therapy].
    Tsuji M; Ichihashi M; Mishima Y
    Nihon Hifuka Gakkai Zasshi; 1983 Jun; 93(7):773-8. PubMed ID: 6620640
    [No Abstract]   [Full Text] [Related]  

  • 7. Boronated compounds for neutron capture therapy.
    Alam F; Bapat BV; Soloway AH; Barth RF; Mafune N; Adams DM
    Strahlenther Onkol; 1989; 165(2-3):121-3. PubMed ID: 2494714
    [No Abstract]   [Full Text] [Related]  

  • 8. [Neutron capture therapy for cancer].
    Fukuda H; Ichihashi M; Mishima Y
    Gan To Kagaku Ryoho; 1994 Feb; 21(3):374-8. PubMed ID: 8109994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human melanoma treated by boron neutron capture therapy: comparison of the clinical response with the predicted response.
    Hiratsuka J; Fukuda H; Kobayashi T; Kanda K; Honda C; Ichihashi M; Mishima Y
    Radiat Med; 1996; 14(5):257-63. PubMed ID: 8988505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plan for synthesis of biomolecules for neutron capture therapy of cervical carcinoma.
    Wongwiechintana C; Choonchartprasert S; Tampitak S; Prachayasittigul S
    Strahlenther Onkol; 1989; 165(2-3):125-6. PubMed ID: 2494715
    [No Abstract]   [Full Text] [Related]  

  • 11. Fractionation and other clinical considerations in boron neutron capture therapy.
    Durrant KR; Hopewell JW
    Strahlenther Onkol; 1989; 165(2-3):231-3. PubMed ID: 2494739
    [No Abstract]   [Full Text] [Related]  

  • 12. Boronated antibodies for neutron capture therapy.
    Abraham R; Müller R; Gabel D
    Strahlenther Onkol; 1989; 165(2-3):148-51. PubMed ID: 2494718
    [No Abstract]   [Full Text] [Related]  

  • 13. In situ measurement on 10B concentrations and absorbed dose estimations in human malignant melanoma treated by BNCT.
    Kobayashi T; Kanda K; Mishima Y
    Strahlenther Onkol; 1989; 165(2-3):104-6. PubMed ID: 2494708
    [No Abstract]   [Full Text] [Related]  

  • 14. Biological effects of intermediate-energy neutrons and their relevance to boron neutron capture therapy.
    Mill AJ
    Strahlenther Onkol; 1989; 165(2-3):193-6. PubMed ID: 2494726
    [No Abstract]   [Full Text] [Related]  

  • 15. Fast neutrons from the Essen cyclotron can be used successfully for neutron capture experiments in vitro.
    Ziegler W; Sauerwein W; Streffer C
    Strahlenther Onkol; 1989; 165(2-3):210-2. PubMed ID: 2494731
    [No Abstract]   [Full Text] [Related]  

  • 16. A proposed protocol for clinical trials of boron neutron capture therapy in glioblastoma multiforme.
    Dorn RV; Spickard JH; Griebenow ML
    Strahlenther Onkol; 1989; 165(2-3):233-4. PubMed ID: 2538939
    [No Abstract]   [Full Text] [Related]  

  • 17. A multidisciplinary program leading to a clinical trial of neutron capture therapy at Tufts-New England Medical Center and the Massachusetts Institute of Technology.
    Zamenhof RG; Madoc-Jones H; Harling OK; Bernard JA
    Strahlenther Onkol; 1989; 165(2-3):254-7. PubMed ID: 2538941
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose bracketing in boron neutron capture therapy.
    Gahbauer R; Kanellitsas C; Blue T; Wang C; Clendenon N; Fairchild R; Laster B; McGregor J; Goodman J
    Strahlenther Onkol; 1989; 165(2-3):229-30. PubMed ID: 2494738
    [No Abstract]   [Full Text] [Related]  

  • 19. Method of in situ dosimetry in boron neutron capture therapy.
    Blue J; Roberts W; Blue T; Wang C
    Strahlenther Onkol; 1989; 165(2-3):109-12. PubMed ID: 2494710
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective targeting of boronophenylalanine to melanoma in BALB/c mice for neutron capture therapy.
    Coderre JA; Glass JD; Fairchild RG; Roy U; Cohen S; Fand I
    Cancer Res; 1987 Dec; 47(23):6377-83. PubMed ID: 3677082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.